A detailed history of Leavell Investment Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Leavell Investment Management, Inc. holds 36,426 shares of BMY stock, worth $2.12 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
36,426
Previous 22,372 62.82%
Holding current value
$2.12 Million
Previous $929,000 102.91%
% of portfolio
0.1%
Previous 0.05%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$39.66 - $51.75 $557,381 - $727,294
14,054 Added 62.82%
36,426 $1.89 Million
Q2 2024

Jul 17, 2024

SELL
$40.25 - $52.99 $148,925 - $196,063
-3,700 Reduced 14.19%
22,372 $929,000
Q1 2024

Apr 24, 2024

BUY
$47.98 - $54.4 $7,580 - $8,595
158 Added 0.61%
26,072 $1.41 Million
Q4 2023

Jan 23, 2024

SELL
$48.48 - $57.85 $97,444 - $116,278
-2,010 Reduced 7.2%
25,914 $1.33 Million
Q3 2023

Oct 16, 2023

BUY
$57.89 - $64.73 $126,721 - $141,693
2,189 Added 8.51%
27,924 $1.62 Million
Q2 2023

Jul 19, 2023

SELL
$63.71 - $70.74 $39,691 - $44,071
-623 Reduced 2.36%
25,735 $1.65 Million
Q1 2023

Apr 13, 2023

SELL
$65.71 - $74.53 $158,886 - $180,213
-2,418 Reduced 8.4%
26,358 $1.83 Million
Q4 2022

Jan 17, 2023

SELL
$68.48 - $81.09 $7,121 - $8,433
-104 Reduced 0.36%
28,776 $2.07 Million
Q3 2022

Oct 17, 2022

SELL
$0.13 - $76.84 $4 - $2,766
-36 Reduced 0.12%
28,880 $2.05 Million
Q2 2022

Jul 28, 2022

BUY
$72.62 - $79.98 $37,907 - $41,749
522 Added 1.84%
28,916 $2.24 Million
Q1 2022

Apr 21, 2022

SELL
$61.48 - $73.72 $17,952 - $21,526
-292 Reduced 1.02%
28,394 $2.09 Million
Q4 2021

Jan 20, 2022

SELL
$53.63 - $62.52 $965 - $1,125
-18 Reduced 0.06%
28,686 $1.79 Million
Q3 2021

Oct 26, 2021

SELL
$59.17 - $69.31 $339,990 - $398,255
-5,746 Reduced 16.68%
28,704 $1.71 Million
Q1 2021

Apr 15, 2021

BUY
$59.34 - $66.74 $180,215 - $202,689
3,037 Added 9.67%
34,450 $2.19 Million
Q4 2020

Jan 26, 2021

SELL
$57.74 - $65.43 $685,720 - $777,046
-11,876 Reduced 27.43%
31,413 $1.96 Million
Q3 2020

Oct 27, 2020

SELL
$57.43 - $63.64 $162,756 - $180,355
-2,834 Reduced 6.14%
43,289 $2.61 Million
Q2 2020

Jul 23, 2020

BUY
$54.82 - $64.09 $81,955 - $95,814
1,495 Added 3.35%
46,123 $2.71 Million
Q1 2020

Apr 16, 2020

BUY
$46.4 - $67.43 $31,180 - $45,312
672 Added 1.53%
44,628 $2.49 Million
Q4 2019

Jan 22, 2020

BUY
$49.21 - $64.19 $565,816 - $738,056
11,498 Added 35.42%
43,956 $2.82 Million
Q3 2019

Oct 28, 2019

BUY
$42.77 - $50.71 $492,068 - $583,418
11,505 Added 54.91%
32,458 $1.65 Million
Q2 2019

Jul 18, 2019

SELL
$44.62 - $49.34 $13,698 - $15,147
-307 Reduced 1.44%
20,953 $950,000
Q1 2019

Apr 16, 2019

BUY
$45.12 - $53.8 $15,792 - $18,830
350 Added 1.67%
21,260 $1.01 Million
Q2 2018

Jul 23, 2018

SELL
$50.53 - $62.98 $2,526 - $3,149
-50 Reduced 0.24%
20,910 $1.16 Million
Q1 2018

Apr 25, 2018

BUY
$59.92 - $68.98 $23,308 - $26,833
389 Added 1.89%
20,960 $1.33 Million
Q4 2017

Jan 11, 2018

SELL
$59.94 - $65.35 $5,994 - $6,534
-100 Reduced 0.48%
20,571 $1.26 Million
Q3 2017

Oct 25, 2017

BUY
$55.23 - $63.74 $1.14 Million - $1.32 Million
20,671
20,671 $1.32 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Leavell Investment Management, Inc. Portfolio

Follow Leavell Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leavell Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Leavell Investment Management, Inc. with notifications on news.